Caramels are first in line for EFSA's reassessment of 12 major food and beverage colorants.
EFSA (Parma, Italy) has released a 2012 report outlining consumer exposure to caramel colorants, as requested by the European Commission (EC).
In 2011, EFSA adopted a scientific opinion on the safety of caramel colorants as food additives, with individual limits based on potentially toxic compounds. But because of concern that certain populations may exceed acceptable dietary intake (ADI) levels for these and other colorants, the EC in May 2012 called for priority reassessment of 12 major food colorants-starting with caramels used for browning of foods and beverages.
The agency’s new assessment covers caramel colorants E 150a, E 150c, and E 150d. (Because consumption levels for E 150b were below the ADI in EFSA’s 2011 investigation, this color was left out of the latest assessment.) In most cases, exposure to caramel color is now thought to be considerably lower than estimates expressed in 2011. However, exposure to E 150c, often used in toddler bakery wares and alcoholic beverages, may be too high in toddlers and adults with high intake.
A combined ADI limit for all four caramels is now set at 300 mg/kg of body weight daily, with a restrictive 100 mg/kg of body weight daily for 150c.
The new estimates are based on data provided by industry for the EFSA Comprehensive European Food Consumption Database. In order of priority, EFSA will next reassess exposure levels for curcumin (E 100), amaranth (E 123), and brown HT (E 155); azorubine/carmoisine (E 122), allura red AC (E 129), and brilliant black BN (E 151); and quinolone yellow (E 104), sunset yellow (E 110), and ponceau 4R (E 124).
HHS announces restructuring plans to consolidate divisions and downsize workforce
Published: March 27th 2025 | Updated: March 27th 2025According to the announcement, the restructuring will save taxpayers $1.8 billion per year by reducing the workforce by 10,000 full-time employees and consolidating the department’s 28 divisions into 15 new divisions.
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.